Supernus Pharmaceuticals reported $11.35M in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Aurora Cannabis Inc ACB:CN -996333000 932.06M
Bristol Myers Squibb BMY:US $ 2590M 37M
Canopy Growth Corp WEED:CN C$ -1838229000 1.3B
Cara Therapeutics CARA:US $ -4472000 23.44M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Eisai 4523:JP Y 7434M 28237M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Horizon Pharma HZNP:US $ 88.56M 105.76M
JAZZ PHA JAZZ:US $ 85.55M 2M
Lannett LCI:US $ -22.08M 46M
Marinus Pharmaceuticals MRNS:US $ -36.77M 20.06M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
United Therapeutics UTHR:US $ 201.8M 84.5M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 10.16M